Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cryoballoon Pulmonary Vein Isolation as First Line Treatment for Typical Atrial Flutter

NCT03401099 is registered in ClinicalTrials.gov with Liverpool Heart and Chest Hospital NHS Foundation Trust as lead sponsor.

NCT NCT03401099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03401099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cryoballoon Pulmonary Vein Isolation as First Line Treatment for Typical Atrial Flutter
Lead sponsor
Liverpool Heart and Chest Hospital NHS Foundation Trust
Phase
Not applicable
Overall status
Completed
Start date
August 17, 2018
Completion date
November 1, 2023
Enrollment
113 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

atrial flutter typical